High rates of transmitted drug resistance among newly-diagnosed antiretroviral naïve HIV patients in Northern Greece, data from 2009-2011

Clinical Microbiology and Infection

Volumn 19, Issue 3, 2013, Pages

  Skoura, L ^a   Metallidis, S ^b   Pilalas, D ^b   Kourelis, A ^a   Margariti, A ^a   Papadimitriou, E ^a   Antoniadou, Z A ^a   Chrysanthidis, T ^b   Tsachouridou, O ^b   Kollaras, P ^b   Nikolaidis, P ^b   Malisiovas, N ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Epidemiology; Greece; Human immunodeficiency virus acquired immune deficiency syndrome; Subtype A; Transmitted drug resistance

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; FEMALE; GREECE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84874305782     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12124     Document Type: Article

References (15)

1. Vercauteren J, Wensing AM, van de Vijver DA et al. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis 2009; 200: 1503-1508.
2. UK Collaborative Group on HIV Drug Resistance. Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study. BMJ 2012; 345: e5253.
3. Colafigli M, Torti C, Trecarichi EM et al. Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. Clin Microbiol Infect 2012; 18: E299-E304.
4. Audelin AM, Gerstoft J, Obel N et al. Molecular phylogenetics of transmitted drug resistance in newly diagnosed HIV Type 1 individuals in Denmark: a nation-wide study. AIDS Res Hum Retroviruses 2011; 27: 1283-1290.
5. Karlsson A, Bjorkman P, Bratt G et al. Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010. PLoS ONE 2012; 7: e33484.
6. Bartmeyer B, Kuecherer C, Houareau C et al. Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort. PLoS ONE 2010; 5: e1271.
7. Skoura L, Metallidis S, Buckton AJ et al. Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece. J Antimicrob Chemother 2011; 66: 2831-2837.
8. Metallidis S, Pilalas D, Skoura L et al. Time trends and correlates of late presentation for HIV care in Northern Greece during the decade 2000-2010. J Int AIDS Soc 2012; 15: 17395.
9. Bennett DE, Camacho RJ, Otelea D et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS ONE 2009; 4: e4724.
10. Burchell AN, Bayoumi AM, Rourke SB et al. Increase in transmitted HIV drug resistance among persons undergoing genotypic resistance testing in Ontario, Canada, 2002-09. J Antimicrob Chemother 2012; 67: 2755-2765.
11. Kentikelenis A, Karanikolos M, Papanicolas I, Basu S, McKee M, Stuckler D. Health effects of financial crisis: omens of a Greek tragedy. Lancet 2011; 378: 1457-1458.
12. Paraskevis D, Nikolopoulos G, Tsiara C et al. HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill 2011; 16: pii=19962.
13. Paraskevis D, Magiorkinis E, Magiorkinis G et al. Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. J Infect Dis 2007; 196: 1167-1176.
14. Yanik EL, Napravnik S, Hurt CB et al. Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients. J Acquir Immune Defic Syndr 2012; 61: 258-262.
15. Wittkop L, Gunthard HF, De Wolf F et al. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis 2011; 11: 363-371.